FDA-approved medicines exist for specific indications

HMG

Urinary menotropins (FSH+LH biologic mixture) — labeled ART/infertility object; no athletic framing.

Editorial review:

What evidence says

Evidence snapshot

This drawer marks papers. It is not a plan, a dose, or a source. A paper is a bounded report. It is not a protocol. Grades name the object. They are not a safety rating.

Identity lock — labeled fertility object. HMG / menotropins are urinary-derived gonadotropin preparations containing FSH and LH activity, used for ovulation induction and controlled ovarian stimulation in infertility / ART. Modern highly purified products (HP-hMG / Menopur-class) are pharmaceutical fertility objects. No single small-molecule PubChem CID — HMG is a biologic mixture, not a research peptide monomer. ≠ pure recombinant FSH alone, ≠ hCG, ≠ gonadorelin. This drawer marks papers. It is not use advice.

Bottom line

Menotropins remain a standard ART stimulation option with randomized comparisons and network meta-analysis vs recombinant FSH strategies. Evidence grades belong to infertility medicine. There is no performance-enhancement evidence map — none should be invented.

Papers

Product / class profile (labeled fertility)

PMID 30264288 — Deeks 2018

Tested: clinical drug profile of highly purified human menopausal gonadotropin (Menopur) in infertility use.

Does not show: non-fertility indications or research-peptide equivalence.

PMID 34622768 — Jonker 2021

Tested: bioequivalence of liquid HP-hMG pre-filled pen versus powder pharmaceutical presentations (product-science comparison).

Does not show: a new efficacy indication beyond fertility labeling.

Controlled ovarian stimulation — comparative trials / synthesis

PMID 18583332 — Bosch 2008

Tested: randomized comparison of highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists.

Does not show: male hypogonadism or physique outcomes.

PMID 18681992 — Platteau 2008

Tested: HP-hMG versus recombinant FSH for ovarian stimulation in IVF cycles.

Does not show: that HMG equals the hCG trigger object.

PMID 32416978 — Witz 2020

Tested: randomized, assessor-blinded trial of HP-hMG vs recombinant FSH in high responders undergoing IVF.

Does not show: non-ART uses.

PMID 34886872 — Kirshenbaum 2021

Tested: comparison framing of recombinant FSH+LH versus human menopausal gonadotropins regarding source of LH bioactivity.

Does not show: that all LH-activity sources are clinically identical in every protocol.

PMID 40590303 — Melo 2025

Tested: Cochrane network meta-analysis of controlled ovarian stimulation protocols for assisted reproduction (menotropin-containing strategies among compared arms).

Does not show: consumer or athletic “HMG peptide” claims.

What is not established

Any athletic or physique use for HMG/menotropins. That HMG equals recombinant FSH-only products or equals hCG. Product identity for unregulated “HMG” preparations outside pharmaceutical fertility supply chains. This drawer does not provide use advice, schedules, or sourcing.

Selected sources

30264288 34622768 18583332 18681992 32416978 34886872 40590303

What people discuss

Reported experiences

Reported topics are not established benefits.

Watch for

Risks and unknowns

Context matters. Approval of one medicine, formulation, or use does not establish approval of products sold online or other uses. This page is educational and does not provide dosing or treatment advice.

Member discussion

Compare experiences with care.

Before posting: Describe firsthand observations and uncertainty. Do not prescribe, arrange transactions, or post private health information.

◎Verified members

Join the discussion

Verified members can contribute to compound conversations.

No approved member reports yet. Thoughtful first contributions are welcome.